Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease
Publication year
2019Source
Arthritis Research & Therapy, 21, 1, (2019), pp. 54ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Internal Medicine
Journal title
Arthritis Research & Therapy
Volume
vol. 21
Issue
iss. 1
Page start
p. 54
Subject
Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227436]
- Electronic publications [107269]
- Faculty of Medical Sciences [86157]
- Open Access publications [76399]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.